10E8 | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

376 results for “10E8”

HIV Vaccine Breakthrough: New Candidate Successfully Generates Broadly Neutralizing Antibodies

Coherent Biopharma's CBP-1008 Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Clear Cell Carcinoma

MB-108 Receives FDA Orphan Drug Designation for Malignant Glioma

FDA Grants Orphan Drug Designation to Mustang Bio's MB-108 for Malignant Glioma

Dynavax Technologies' Z-1018 Shingles Vaccine Shows Promise in Phase 1/2 Trial with Improved Safety Profile

Dynavax's Z-1018 Shingles Vaccine Matches GSK's Shingrix Efficacy with Superior Tolerability in Phase I/II Trial

Cytonics' CYT-108 Shows Favorable Safety Profile in Phase 1 Osteoarthritis Trial

Aquestive Therapeutics Advances Anaphylm and AQST-108, Reports Q3 2024 Financial Results

Asgard Therapeutics Appoints Veteran Oncologist as CMO to Advance Novel Cancer Immunotherapy AT-108

Cytonics Completes Enrollment in Phase 1 Trial of CYT-108 for Knee Osteoarthritis

Page 1 of 2